Open Label Extension Trial of Idebenone for Primary Progressive Multiple Sclerosis
Status: Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 16 Nov 2018
Price : $35 *
At a glance
- Drugs Idebenone (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Acronyms IPPoMS-E
- 03 Oct 2018 Status changed from recruiting to active, no longer recruiting.
- 02 Oct 2015 Planned End Date changed from 1 Oct 2018 to 1 Aug 2019 as per ClinicalTrials.gov record.
- 22 May 2013 New trial record